Global Human Insulin Market (Product Type, Brand and Geography) 2013-2020
Big Market Research, Global Human Insulin Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Browse full report @ http://www.bigmarketresearch.com/human-insulin-market Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
Big Market Research, Global Human Insulin Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Browse full report @ http://www.bigmarketresearch.com/human-insulin-market
Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Global</strong> <strong>Human</strong> <strong>Insulin</strong><br />
<strong>Market</strong> (<strong>Product</strong> <strong>Type</strong>,<br />
<strong>Br<strong>and</strong></strong> <strong>and</strong> <strong>Geography</strong>)<br />
<strong>2013</strong>-<strong>2020</strong><br />
www.bigmarketresearch.com
Report Description<br />
<strong>Insulin</strong> regulates fat <strong>and</strong> carbohydrate metabolism in the body. It is a peptide hormone,<br />
which is secreted in the pancreas by beta cells of the islets of Langerhans <strong>and</strong> it helps to<br />
regulate the glucose metabolism. It causes skeletal muscle cells <strong>and</strong> fat tissues to absorb<br />
glucose from the blood. The global human insulin market is expected to grow at healthy<br />
CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth<br />
analysis of the global human insulin market focuses on various aspects of the market<br />
such as market trends, market drivers, restraints <strong>and</strong> opportunities. Competitive<br />
l<strong>and</strong>scape section focuses on key leaders within the global human insulin market <strong>and</strong><br />
their major growth strategies. Detailed analysis of segments helps in underst<strong>and</strong>ing<br />
market dynamics <strong>and</strong> would be beneficial for market professionals.<br />
Browse complete report @<br />
http://www.bigmarketresearch.com/human-insulin-market
Report Description<br />
The growth of global human insulin market is primarily attributed to rising prevalence of<br />
diabetes. The factors that contribute to growing number of diabetic patient globally<br />
include changes in lifestyles, growing number of obese as well as geriatric population <strong>and</strong><br />
inadequate healthcare services. Favorable government policies <strong>and</strong> technological<br />
advances such as innovation of insulin pens have also fueled the growth of this market.<br />
However, cost of production, manufacturing complexities <strong>and</strong> critical regulatory<br />
requirements for the approval of biotechnology derived products are the factors that<br />
could hinder the growth of global human insulin market. Pipeline insulin products <strong>and</strong><br />
untapped emerging economies are the promising opportunities for the manufacturers of<br />
global human insulin.<br />
Feel free to get enquire about report @<br />
http://www.bigmarketresearch.com/report-enquiry/22948
Report Description<br />
<strong>Global</strong> <strong>Human</strong> <strong>Insulin</strong> <strong>Market</strong> by <strong>Type</strong>s<br />
The global human insulin market is segmented by product type into Traditional <strong>and</strong><br />
Modern <strong>Human</strong> <strong>Insulin</strong>. Traditional <strong>Human</strong> <strong>Insulin</strong> is segmented as Premixed,<br />
Intermediate Acting <strong>and</strong> Short Acting <strong>Human</strong> <strong>Insulin</strong>, whereas Modern <strong>Human</strong> <strong>Insulin</strong><br />
includes Premixed, Long Acting <strong>and</strong> Rapid Acting types. Long acting modern insulin <strong>and</strong><br />
premixed modern insulin are the fastest growing categories of this segment.<br />
<strong>Global</strong> <strong>Human</strong> <strong>Insulin</strong> <strong>Market</strong> by <strong>Br<strong>and</strong></strong>s<br />
According to the br<strong>and</strong>s available into the market, the global human insulin market is<br />
classified as traditional <strong>and</strong> modern human insulin br<strong>and</strong>s. Traditional br<strong>and</strong>s include<br />
Humulin, Actrapid <strong>and</strong> Insuman, whereas, modern br<strong>and</strong>s include Humalog, Novomix,<br />
Novorapid, Lantus, Levemir <strong>and</strong> Apidra. Over the past few years, biosimilars has gained<br />
popularity in comparison to br<strong>and</strong>ed drugs. Basalog, Wosulin <strong>and</strong> Glaritus are the<br />
biosimilars available in Asia-Pacific region.<br />
Request for Table of Contents @<br />
http://www.bigmarketresearch.com/human-insulin-market
Report Description<br />
<strong>Global</strong> <strong>Human</strong> <strong>Insulin</strong> <strong>Market</strong> by <strong>Geography</strong><br />
Geographically, global human insulin market is segmented into North America, Europe,<br />
Asia-Pacific <strong>and</strong> LAMEA. North America dominates the global human insulin market<br />
owing to high prevalence of diabetes <strong>and</strong> technological advances in effective insulin<br />
delivery. Asia-Pacific <strong>and</strong> LAMEA are the fastest growing geographic segments due to high<br />
diabetes incidences, government support <strong>and</strong> improving healthcare conditions.<br />
Competitive L<strong>and</strong>scape<br />
Eli Lilly, GlaxoSmithCline, Biocon, Sanofi Aventis, Julphar, Novo Nordisk, SemBioSys, <strong>and</strong><br />
Wockhardt are some of the key players of global human insulin market. Manufacturers<br />
are focusing to develop the advanced techniques of insulin delivery to gain the<br />
competitive advantage. Development of biosimilars is a booming trend in global human<br />
insulin market <strong>and</strong> Wockhardt <strong>and</strong> Biocon have launched their biosimilars products in<br />
Asia-Pacific region.
Report Description<br />
High Level Analysis<br />
The study identifies the potential market drivers, challenges <strong>and</strong> trends. Competitive<br />
l<strong>and</strong>scape section provides explicit information of the big players ruling the global human<br />
insulin market, their operating strategies, new launches, pipeline products <strong>and</strong> clinical<br />
trials. Porter’s Five Forces analysis has been used to determine the attractiveness of<br />
global human insulin market. Large pool of diabetic population <strong>and</strong> high cost of<br />
technology required to manufacture innovative insulin delivery devices are the factors<br />
that tend to increase the supplier’s bargaining power. High cost of down streaming<br />
process <strong>and</strong> manunufacturing complexities limit the new players in entering the market.<br />
Industrial rivalry is intense due to patent expiration of major br<strong>and</strong>s <strong>and</strong> growing dem<strong>and</strong><br />
for biosimilars products.<br />
Request for Table of Contents @<br />
http://www.bigmarketresearch.com/human-insulin-market
Report Description<br />
KEY BENEFITS<br />
This report offers the following benefits in particular:<br />
• Comprehensive coverage of global human insulin market along with disease overview,<br />
market trends, drivers <strong>and</strong> restraints<br />
• Thorough attention is given to leading company portfolios, pipeline research, new<br />
launches <strong>and</strong> competitive l<strong>and</strong>scape of top players<br />
• Explicit information on current clinical trials <strong>and</strong> R&D activities would be beneficial to<br />
underst<strong>and</strong> the future market trends<br />
• Insightful analysis of different segments helps to recognize <strong>and</strong> capitalize future<br />
opportunities within global human insulin market
Report Description<br />
KEY DELIVERABLES<br />
The global human insulin market is segmented into three major categories such as,<br />
<strong>Product</strong> <strong>Type</strong>, <strong>Br<strong>and</strong></strong> <strong>and</strong> <strong>Geography</strong>.<br />
MARKET BY TYPES<br />
Traditional <strong>Human</strong> <strong>Insulin</strong><br />
Premixed Traditional<br />
Intermediate Acting<br />
Short Acting<br />
Modern <strong>Human</strong> <strong>Insulin</strong><br />
Premixed Modern<br />
Long Acting<br />
Rapid Acting
Report Description<br />
MARKET BY BRAND<br />
• Traditional <strong>Human</strong> <strong>Insulin</strong> <strong>Br<strong>and</strong></strong>s<br />
• Humulin<br />
• Actrapid<br />
• Insuman<br />
• Modern <strong>Human</strong> <strong>Insulin</strong> <strong>Br<strong>and</strong></strong>s<br />
• Humalog<br />
• Novomix<br />
• Novorapid<br />
• Lantus<br />
• Levemir<br />
• Apidra<br />
MARKET BY GEOGRAPHY<br />
• North America<br />
• Europe<br />
• Asia-Pacific<br />
• LAMEA
FOR MORE DETAILS<br />
Visit us at :<br />
http://www.bigmarketresearch.com/human-insulin-market<br />
Stay With Us:<br />
TELEPHONE: +1 (855) 711-1555<br />
E-MAIL: help@bigmarketresearch.com<br />
5933 NE Win Sivers Drive,<br />
#205, Portl<strong>and</strong>, OR 97220<br />
United States
Change language